This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
9
Check minimum number of events None
9
Include endpoints None
9
Remove individuals based on genotype QC
9
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Protrusioacetabuli based on the number of shared cases.
Broader endpoints:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Injury, poisoning and certain other consequences of external causes
- Anti-inflammatory and antirheumatic products, non-steroids
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 9 | 6 | - |
Unadjusted prevalence (%) | 0.00 | 0.00 | - |
Mean age at first event (years) | 54.27 | 59.20 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: M13_PROTRUSIOACETABULI – Protrusioacetabuli
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Protrusioacetabuli
↥Endpoint not on priority list, no data to show.